A diagnosis usually marks when a disease crosses a threshold, not when it starts. By then it has often been building quietly for years.
Type 2 diabetes starts years before diagnosis
A classic analysis estimated that type 2 diabetes begins at least 4 to 7 years before diagnosis, possibly 9 to 12. In U.S. data, about 1 in 5 people already had diabetes-related eye damage when diagnosed.
In a long-term British study, blood sugar and insulin sensitivity were already shifting 3 to 6 years before diagnosis. About 115 million U.S. adults have prediabetes, and about 28% of adults with diabetes (11 million) are undiagnosed.
Other diseases are also found late
- High blood pressure. Worldwide in 2019, only 59% of women and 49% of men with high blood pressure had ever been diagnosed, and fewer than 1 in 4 had it controlled. Heart and stroke risk climbs steadily from 115/75 upward.
- Kidney disease. About 9 in 10 U.S. adults with chronic kidney disease don’t know they have it.
- Alzheimer’s disease. In an inherited form, amyloid (a protein that clumps in the brain) began building up about 25 years before expected symptoms. Dementia was diagnosed, on average, 3 years after that expected start.
- Parkinson’s disease. When movement symptoms start, about two-thirds of the dopamine-making cells in the most affected brain area may already be gone.
- Colorectal cancer. Five-year survival is about 91% if it’s caught before spreading, and about 17% once it reaches distant organs. Only about a third of cases are caught early.
Why the system catches disease late
- Diagnosis is a cutoff, but risk is a slope. Your body doesn’t change suddenly at a blood sugar, blood pressure, or kidney cutoff. People just under one often hear they’re fine, even if their numbers have climbed for years.
- Many diseases are silent until advanced. High blood pressure, high cholesterol, prediabetes, early kidney disease, and many cancers usually cause no symptoms. Care that waits for symptoms starts late.
- Doctors lack time. One analysis estimated a primary care doctor would need about 27 hours a day to give a typical patient panel all recommended care, 14 of them for prevention. Careful review of early warning signs usually gets cut.
- The system pays more for treatment than prevention. Most U.S. healthcare payment rewards visits, tests, and procedures for people already sick. Keeping someone well is hard to bill for, and nobody sees the heart attack that never happened.
- Checkups give snapshots, not trends. A single normal result can hide a steady drift, and results from different clinics rarely get compared.
- Symptoms get missed. One estimate found about 795,000 Americans die or are permanently disabled each year because a dangerous disease, like stroke, sepsis, or cancer, was misdiagnosed. Vague, slow-building symptoms are easy to dismiss as stress, aging, or tiredness.
Delays in psoriatic arthritis are linked to joint damage
Some people with psoriasis develop psoriatic arthritis, which can permanently damage joints. In one study, the typical wait from first joint symptoms to seeing a rheumatologist (a joint specialist) was a year, and only 30% were seen within 6 months. Even a 6-month delay was linked to more joint damage on X-rays and worse physical function years later.
If you have psoriasis and notice joint pain, stiffness, swollen fingers or toes, or heel pain, tell your clinician early and ask about a rheumatology referral.
Limits of early detection
- Earlier isn’t always better. Screening can find abnormalities that would never cause harm, leading to anxiety and unneeded treatment. The goal is noticing the right things early, not testing everything.
- Doctors aren’t the villains. Most want more time for prevention. Short visits, payment models, and scattered records limit them.
- For some diseases, early detection doesn’t yet change the outcome. For diabetes, high blood pressure, kidney disease, many cancers, and inflammatory arthritis, it clearly does.
How to catch problems early
- Ask for the number, not just “normal.” Know your blood pressure, A1c or fasting glucose, cholesterol, and kidney numbers, and where each sits in the range.
- Gather your last few years of lab results (patient portals usually have them) and compare year over year. Look for drift, even within the normal range. Ask, “Where will this be in five years if nothing changes?”
- Know the in-between zones. An A1c of 5.7% to 6.4% is prediabetes. A top blood pressure number of 120 to 129 is elevated. These are the best times to act.
- If you have diabetes or high blood pressure, ask about a urine albumin test and regular kidney function checks.
- Log recurring symptoms with dates. “I’ve felt exhausted 4 days a week for 2 months, mostly after poor sleep” is harder to dismiss than “I’ve been tired lately.”
- Name your worry: “Could this be ___? What would rule it out?” This helps your clinician look beyond the most common explanation.
- Know your family history, and follow evidence-based screening guidance for your age.
- If anything is trending the wrong way, book a visit and bring your log.
What to track
Track your numbers, symptoms, sleep, and stress. A daily check-in shows trends that single checkups miss.
Selected sources
- Harris MI, et al. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care. 1992. DOI: 10.2337/diacare.15.7.815
- Tabák AG, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009. DOI: 10.1016/S0140-6736(09)60619-X
- Centers for Disease Control and Prevention. National Diabetes Statistics Report. cdc.gov
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019. Lancet. 2021. DOI: 10.1016/S0140-6736(21)01330-1
- Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002. DOI: 10.1016/S0140-6736(02)11911-8
- Centers for Disease Control and Prevention. Chronic kidney disease in the United States. cdc.gov
- Bateman RJ, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012. DOI: 10.1056/NEJMoa1202753
- Fearnley JM, Lees AJ. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain. 1991. DOI: 10.1093/brain/114.5.2283
- National Cancer Institute SEER Program. Cancer stat facts: colorectal cancer. seer.cancer.gov
- Porter J, et al. Revisiting the time needed to provide adult primary care. J Gen Intern Med. 2023. DOI: 10.1007/s11606-022-07707-x
- Newman-Toker DE, et al. Burden of serious harms from diagnostic error in the USA. BMJ Qual Saf. 2024. DOI: 10.1136/bmjqs-2021-014130
- Haroon M, et al. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015. DOI: 10.1136/annrheumdis-2013-204858
- Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010. DOI: 10.1093/jnci/djq099
Want more guides like this?
Get guides in your inbox while we build early access, or keep reading now.
Email me guides More guides